Login / Register

Username:


Password: [Lost?]



New User? Click here for your FREE subscription



Emergency & Urgent Care Providers
Emergency & Urgent Care Providers Emergency & Urgent Care Providers

Follow Us


NEWS-Line on Twitter NEWS-Line on Facebook NEWS-Line on Google+ NEWS-Line on LinkedIn NEWS-Line on Pinterest


Emergency Care Conferences &
Educational Opportunities




Sept. 10 - 13

Skin, Bones, Hearts & Private Parts 2019 Pensacola Beach CME/CE Conference

Skin, Bones, Hearts & Private Parts

Sept. 17 - 20

29th annual Certification/Recertification Board Review Conference

Emory University School of Medicine Physician Assistant Program

Sept. 19 - 20

AzNA Centennial Celebration: Legacy of Pride, Future of Purpose

Arizona Nurses Associaton

Oct. 8 - 11

Skin, Bones, Hearts & Private Parts 2019 San Antonio CME/CE Conference

Skin, Bones, Hearts & Private Parts

Oct. 17 - 20

AASPA 19th CME Meeting & Surgical Update

American Association of Surgical Physician Assistants

More Events

Intranasal Sufentanil As Good As IV Morphine For Emergency Pain Relief, Study Finds | NEWS-Line for Pharmacists

Intranasal Sufentanil As Good As IV Morphine For Emergency Pain Relief, Study Finds


Source:

In patients presenting to an emergency department with severe traumatic pain, intranasal sufentanil was as good as standard-of-care intravenous morphine for pain relief, according to a new study published this week in PLOS Medicine by Marc Blancher of Grenoble Alpes University Hospital, France, and colleagues.

Intravenous morphine is the most commonly used strong analgesic for relieving acute pain in the emergency room, but the need to get an IV line started before administration limits its rapid use. In the new study, researchers randomized 136 patients who presented to the emergency departments of six hospitals across France.

Patients ranged in age from 18 to 75 years old and had traumatic pain self-evaluated as at least a six out of ten on a rating scale. 69 patients received intranasal sufentanil plus an intravenous placebo and 67 patients received intravenous morphine plus an intranasal placebo.

Patients' pain rating dropped by 4.1 points (97.5% CI -4.6 to -3.6) in the 30 minutes after analgesic administration in the group receiving intravenous morphine, and by 5.2 points (-5.7 to -4.6) with intranasal sufentanil. Intranasal sufentanil was shown to be non-inferior to intravenous morphine in terms of pain control at 30 minutes (p<0.001), as well as superior to morphine (p=0.034). 6 severe adverse events were observed in the intranasal sufentanil group and 2 in the intravenous morphine group, indicating that further research will be needed on the safety of intranasal sufentanil. Co-analgesics were used more often in the intranasal sufentanil group.

"The use of intranasal sufentanil might provide an easy and time saving solution in the management of acute pain," the authors say.

Source:PLOS

Photo Credit:ENGIN_AKYURT, PIXABAY


Post not cached because it doesn't exist


Share This!


Emergency Care Jobs







Ultrasound, Mammography and Radiologic Technologists,

CareMount Medical, P.C
New York

Registered Nurse Case Manager

Tarzana Treatment Centers
Reseda, California

NPs and/or PAs for Rural Health Clinic and FQHC

Whitney Recruitment LLC
Southwest, Michigan

Nurse Practitioner

Oak Valley Hospital
Oakdale, California

NAVY MEDICINE - Making a Difference

NAVY MEDICINE
National

NAVY MEDICINE - Making a Difference

NAVY MEDICINE
New York

More Jobs
(Dismiss) Thank you for visiting NEWS-Line! Please sign up, login, or follow us on your favorite social networks
to receive custom tailored eNews, job listings, and educational opportunities for your specific profession.